XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
UNAUDITED CONDENSED STATEMENTS OF CONSOLIDATED CASH FLOWS - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2020
Sep. 30, 2019
Cash flows from operating activities:    
Net income (loss) $ (426,220) $ (7,679)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation, depletion and amortization 31,129 39,696
Impairment expense 455,031 0
(Gain) loss on derivative instruments (70,162) (18,897)
Cash settlements (paid) received on expired derivative instruments 53,076 2,315
Cash settlements (paid) received on terminated derivative instruments 17,977 0
Bad debt expense 470 266
Amortization and write-off of deferred financing costs 3,134 62
Accretion of asset retirement obligations 4,617 4,071
Share-based compensation (see Note 11) (161) 4,073
Settlement of asset retirement obligations (199) (259)
Changes in operating assets and liabilities:    
Accounts receivable 5,769 11,328
Prepaid expenses and other assets 1,080 (1,968)
Payables and accrued liabilities (11,467) (12,115)
Other (476) 4,995
Net cash provided by operating activities 63,598 25,888
Cash flows from investing activities:    
Cash acquired from the Merger 0 19,250
Additions to oil and gas properties (31,234) (63,004)
Additions to other property and equipment (828) 788
Additions to restricted investments 0 (154)
Withdrawals of restricted investments 0 90,000
Proceeds from the sale of other property and equipment 0 31
Net cash provided by (used in) investing activities (32,062) 46,911
Cash flows from financing activities:    
Advances on revolving credit facilities 25,000 103,000
Payments on revolving credit facilities (45,000) (119,000)
Proceeds from the paycheck protection program 5,516 0
Deferred financing costs (65) (832)
Dividends to stockholders (3,786) (8,189)
Common stock repurchased and retired under the share repurchase program 0 (13,251)
Costs incurred in conjunction with tender offer 0 (107)
Restricted units returned to plan (40) (313)
Other 35 156
Net cash provided by (used in) financing activities (18,340) (115,095)
Net change in cash, cash equivalents and restricted cash 13,196 (42,296)
Cash, cash equivalents and restricted cash, beginning of period 325 50,029
Cash, cash equivalents and restricted cash, end of period 13,521 7,733
Midstates [Member]    
Cash flows from financing activities:    
Payments on revolving credit facilities $ 0 $ (76,559)